Schizophrenia Research Study
Researchers at Arch Clinical Trials are studying a drug to help with thinking problems in adults with schizophrenia.
Fast Facts
Diagnosed With Schizophrenia
Receiving Antipsychotic Medication Other Than Clozapine or Cobenfy
Compensation
Provided
Conducted in
St. Louis, MO & Willing to Remain Inpatient (Stay in The Hospital) For up to 4.5 Weeks
Study Background
This study is looking at whether a study drug can improve memory, attention, and other thinking skills when added to your current antipsychotic medicine.
Some adults with schizophrenia have trouble with memory, focus, and problem-solving. A study drug is being tested as a new treatment to see if it can help with these issues.
If you join, you will keep taking your current antipsychotic medicine. You may receive either the study drug or a placebo. Neither you nor your doctors will know which one you get. The study starts with two short outpatient visits for screening, followed by a 32-day stay at the clinic, and ends with a safety follow-up visit
Study Background
This study is looking at whether a study drug can improve memory, attention, and other thinking skills when added to your current antipsychotic medicine.
Some adults with schizophrenia have trouble with memory, focus, and problem-solving. A study drug is being tested as a new treatment to see if it can help with these issues.
If you join, you will keep taking your current antipsychotic medicine. You may receive either the study drug or a placebo. Neither you nor your doctors will know which one you get. The study starts with two short outpatient visits for screening, followed by a 32-day stay at the clinic, and ends with a safety follow-up visit.
Additional Information
The study wants to see if a study drug is safe and can improve thinking problems in adults with schizophrenia.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Diagnosed with schizophrenia
- Receiving antipsychotic medication other than clozapine or Cobenfy
- Willing to remain inpatient (stay in the hospital) for up to 4.5 weeks
- Ages 18-55
- BMI between 18 and 40
Exclusion Criteria:
- Use substances such as cocaine, methamphetamine, or cannabis
- Suicidal ideation
- History of epilepsy
- Pregnant, breastfeeding, or planning to become pregnant in the near future
Two outpatient visits for screening.
Up to 32 days staying at the clinic.
Labs, vitals, EKGs, physical exams, and questionnaires during the stay.
One follow-up visit to check safety.
You will be paid for participating in this research study up to $300 for completing the initial evaluation period. If you live within 55 miles, Lyft rides are available. You will also get 3 meals per day, coffee, and your blood work results if you want them.
There is no cost for you to participate in our research study.